Reuters -- U.S. drugmaker Eli Lilly and Co on Tuesday said it has offered buyouts to 4,000 of its U.S. sales representatives, in hopes several hundred of them will accept the offers ahead of a planned company restructuring.
Reuters -- U.S. drugmaker Eli Lilly and Co on Tuesday said it has offered buyouts to 4,000 of its U.S. sales representatives, in hopes several hundred of them will accept the offers ahead of a planned company restructuring.
